Nearly 88 percent of the survey respondents said they felt “similar” or “better” compared to how they felt in the days following receiving the second vaccine.

More than 30 percent reported one or more side effects, 24 percent reported pain at the site of injection, 6 percent swelling in the injection area and 1 percent swelling in the armpit, the report said.

Nearly 15 percent experienced at least one systemic side effect. People also reported fatigue (9 percent), feeling generally unwell (6.1 percent), headaches and muscle pain (4.3 percent), joint pain (2.1 percent). Few also reported fever, rashes, difficulty breathing and irregular heartbeat or chest pains.

“Although we do not yet have long-term research on the efficacy and safety of the third dose,” Professor Ran Balicer, Clalit’s chief innovation officer, was quoted as saying.

“These findings continue to point to the benefit of immunization now, in addition to careful behaviour by older adults and avoiding gatherings in closed spaces during these weeks,” Balicer added.

At the same time, 14 people out of more than 400,000 who were vaccinated with a third shot were infected with coronavirus, the Post said. Among them two who were hospitalized — one in mild condition and the other in moderate condition, according to the Health Ministry.

The individuals were infected seven or more days after receiving the vaccine. The majority were over age 60, but three were under 60 and had received a third dose because they were immunosuppressed.

Israel is trying to halt a new outbreak of the Delta variant and has also launched a campaign calling teenagers over 12 years old to get vaccinated. The country has also signed a deal with the US drug maker Pfizer to receive a new batch of Covid-19 vaccines in August.

Source: IANS